NSE: ORTINLAB - Ortin Laboratories Limited

六个月盈利: +15.94%
股息率: 0.00%

促销时间表 Ortin Laboratories Limited

zh.porti.ru30.0030.0027.0027.0024.0024.0021.0021.0018.0018.0015.0015.00五月 '23五月 '23六月 '23六月 '23七月 '23七月 '23八月 '23八月 '23九月 '23九月 '23十月 '23十月 '23十一月 '23十一月 '23十二月 '23十二月 '2320242024二月 '24二月 '24三月 '24三月 '24四月 '24四月 '24五月 '24五月 '24六月 '24六月 '24七月 '24七月 '24八月 '24八月 '24九月 '24九月 '24十月 '24十月 '24
下载 SVG
下载 PNG
下载 CSV

关于公司 Ortin Laboratories Limited

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti-diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti-anginal and cardio vascular, and antifungal products.

更多详情
Its formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti retro viral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. The company was formerly known as Ortin Laboratories Limited and changed its name to Ortin Global Limited in June 2024. Ortin Global Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

ISIN INE749B01020
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Сайт https://www.ortinlabsindia.com
Цена ао 20.87
每日价格变化: 0% (20.87)
每周价格变化: -1.32% (21.15)
每月价格变化: -2.75% (21.46)
3个月内价格变化: +5.24% (19.83)
六个月内的价格变化: +15.94% (18)
每年价格变化: +5.67% (19.75)
3年内价格变化: -40.54% (35.1)
5年内价格变化: +206.41% (6.8112)
年初以来价格变化: +0.4331% (20.78)

低估

姓名 意义 年级
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
全部的: 2.5

效率

姓名 意义 年级
ROA, % 0 0
ROE, % 0 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA 0 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -96.31 0
盈利能力 Ebitda, % -91.11 0
盈利能力 EPS, % 0 0
全部的: 0

导师 职称 支付 出生年份
Mr. Sanka Murali Krishna Murthy CEO & MD 1959 (66 年)
Mr. Sanka Srinivasa Kumar CFO & Whole Time Director 1965 (60 年)

地址: India, Hyderabad, D. No. 1-8-B4 F3 HIG - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.ortinlabsindia.com